Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature.
Clinical trials revealed beneficial effects of the broad-spectrum serine protease inhibitor aprotinin on the prevention of ischemia-reperfusion (I/R) injury. The underlying mechanisms remained largely unclear. Using in vivo microscopy on the cremaster muscle of male C57BL/6 mice, aprotinin as well a...
Guardado en:
Autores principales: | Christoph A Reichel, Max Lerchenberger, Bernd Uhl, Markus Rehberg, Nina Berberich, Stefan Zahler, Matthias P Wymann, Fritz Krombach |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f20a55c123c4dfeae4eefe5ebad8b90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Ramsha Aamir, et al.
Publicado: (2021) -
Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin
por: Vivek Gupta, et al.
Publicado: (2017) -
Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema
por: Elsawy MF
Publicado: (2012) -
Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression
por: Gao J, et al.
Publicado: (2017) -
Disrupted Blood‐Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
por: Susmita Bhattarai, et al.
Publicado: (2021)